Stefania Spila Alegiani

2.0k total citations
58 papers, 969 citations indexed

About

Stefania Spila Alegiani is a scholar working on Epidemiology, Neurology and Infectious Diseases. According to data from OpenAlex, Stefania Spila Alegiani has authored 58 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Neurology and 9 papers in Infectious Diseases. Recurrent topics in Stefania Spila Alegiani's work include SARS-CoV-2 and COVID-19 Research (7 papers), Influenza Virus Research Studies (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Stefania Spila Alegiani is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Influenza Virus Research Studies (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Stefania Spila Alegiani collaborates with scholars based in Italy, United States and Sweden. Stefania Spila Alegiani's co-authors include Roberto Raschetti, Marina Maggini, Edoardo Mannucci, Angelo Avogaro, Salvatore Turco, Carlo Giorda, G. Traversa, Flavia Lombardo, Mario Velussi and Ele Ferrannini and has published in prestigious journals such as PLoS ONE, Neurology and Diabetes Care.

In The Last Decade

Stefania Spila Alegiani

55 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Spila Alegiani Italy 17 240 202 142 121 119 58 969
Alfonso Carvajal Spain 20 144 0.6× 80 0.4× 118 0.8× 168 1.4× 86 0.7× 63 1.6k
Tiziana Ciarambino Italy 19 127 0.5× 114 0.6× 137 1.0× 87 0.7× 100 0.8× 65 945
P. Taboulet France 17 129 0.5× 115 0.6× 201 1.4× 96 0.8× 48 0.4× 57 997
Rosa Morros Spain 15 209 0.9× 212 1.0× 166 1.2× 100 0.8× 25 0.2× 80 973
Mojgan Mortazavi Iran 20 168 0.7× 134 0.7× 132 0.9× 144 1.2× 60 0.5× 122 1.3k
Juana Carretero‐Gómez Spain 15 124 0.5× 258 1.3× 110 0.8× 122 1.0× 39 0.3× 95 799
Albert Marchetti United States 17 191 0.8× 240 1.2× 42 0.3× 124 1.0× 151 1.3× 38 922
Mohamed Hassanein United States 17 89 0.4× 241 1.2× 71 0.5× 124 1.0× 62 0.5× 68 934
Elisa Martín‐Merino Spain 19 169 0.7× 118 0.6× 265 1.9× 182 1.5× 31 0.3× 72 1.2k
Ketut Suastika Indonesia 18 158 0.7× 398 2.0× 71 0.5× 150 1.2× 97 0.8× 81 1.1k

Countries citing papers authored by Stefania Spila Alegiani

Since Specialization
Citations

This map shows the geographic impact of Stefania Spila Alegiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Spila Alegiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Spila Alegiani more than expected).

Fields of papers citing papers by Stefania Spila Alegiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Spila Alegiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Spila Alegiani. The network helps show where Stefania Spila Alegiani may publish in the future.

Co-authorship network of co-authors of Stefania Spila Alegiani

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Spila Alegiani. A scholar is included among the top collaborators of Stefania Spila Alegiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Spila Alegiani. Stefania Spila Alegiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellini, Arianna, Massimo Cardillo, Marco Massari, et al.. (2024). Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study. Drug Design Development and Therapy. Volume 18. 53–69. 1 indexed citations
2.
Bellini, Arianna, Silvia Trapani, Massimo Cardillo, et al.. (2024). Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study. BMJ Open. 14(11). e087373–e087373.
3.
Bellini, Arianna, Maurizio Nordio, Eliana Ferroni, et al.. (2024). Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study. PLoS ONE. 19(1). e0295205–e0295205. 2 indexed citations
4.
Mateo‐Urdiales, Alberto, Massimo Fabiani, Flávia Mayer, et al.. (2024). Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021. BMC Public Health. 24(1). 1569–1569.
5.
Massari, Marco, Stefania Spila Alegiani, Massimo Fabiani, et al.. (2021). Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study. Vaccines. 9(7). 716–716. 10 indexed citations
6.
d’Errico, Angelo, et al.. (2021). Use of antipsychotics and long-term risk of parkinsonism. Neurological Sciences. 43(4). 2545–2553. 8 indexed citations
7.
Kurotschka, Peter K, Marco Massari, Roberto Da, et al.. (2020). Broad Spectrum project: factors determining the quality of antibiotic use in primary care: an observational study protocol from Italy. BMJ Open. 10(7). e038843–e038843. 7 indexed citations
8.
Restivo, Vincenzo, Claudio Costantino, Giuseppe Napoli, et al.. (2018). Pap Testing in a High-Income Country with Suboptimal Compliance Levels: A Survey on Acceptance Factors among Sicilian Women. International Journal of Environmental Research and Public Health. 15(9). 1804–1804. 20 indexed citations
9.
Alegiani, Stefania Spila, Roberto Da, Cristina Giambi, Roberto Raschetti, & Stefania Salmaso. (2013). Il registro del vaccino anti-HPV. Recenti Progressi in Medicina. 104(6). 262–6. 2 indexed citations
10.
Raschetti, Roberto, Stefania Spila Alegiani, N. Vanacore, Carla Ancona, & G. Meco. (2009). Mortality in a population-based cohort of patients treated with antiparkinsonian drugs. Acta Neurologica Scandinavica. 97(1). 20–26. 6 indexed citations
11.
Clerici, Francesca, Nicola Vanacore, Stefania Spila Alegiani, et al.. (2009). Memantine in Moderately-Severe-to-Severe Alzheimerʼs Disease. Drugs & Aging. 26(4). 321–332. 17 indexed citations
12.
Avogaro, Angelo, Carlo Giorda, Marina Maggini, et al.. (2007). Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women. Diabetes Care. 30(5). 1241–1247. 123 indexed citations
13.
Raschetti, Roberto, S Salmaso, G. Traversa, et al.. (2005). Mortalita' nei primi due anni di vita in Italia: Sudden Infant Death Syndrome e altre morti inattese. Middle East African Journal of Ophthalmology. 24(3). 126–130. 1 indexed citations
14.
Moro, Maria Luisa, G. Traversa, Annalisa Pantosti, Delia Boccia, & Stefania Spila Alegiani. (2004). The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. European Journal of Clinical Pharmacology. 60(2). 115–119. 32 indexed citations
15.
Giorda, Carlo, et al.. (2003). Secondary prevention of coronary artery disease in high-risk diabetic patients. Nutrition Metabolism and Cardiovascular Diseases. 13(4). 238–243. 8 indexed citations
16.
Raschetti, Roberto, Patrizia Popoli, Roberto Da, et al.. (1995). Gangliosides and Guillain-Barré syndrome. Journal of Clinical Epidemiology. 48(11). 1399–1405. 25 indexed citations
17.
Traversa, G., Francesca Menniti‐Ippolito, Lucio Capurso, et al.. (1995). GASTRODUODENAL TOXICITY OF DIFFERENT NONSTEROIDAL ANTIINFLAMMATORY DRUGS. Epidemiology. 6(1). 49–54. 82 indexed citations
18.
Maggini, Marina, et al.. (1991). Epidemiological use of drug prescriptions as markers of disease frequency: An Italian experience. Journal of Clinical Epidemiology. 44(12). 1299–1307. 25 indexed citations
19.
Maggini, Marco, et al.. (1991). Drug utilization studies within the VIDEOFAR project.. PubMed. 27(2). 201–6.
20.
Bisanti, L, et al.. (1987). A new procedure to assess vital status in cohort studies.. 517–522. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfonso Carvajal Breakdown of academic impact, for papers by Tiziana Ciarambino Breakdown of academic impact, for papers by P. Taboulet Breakdown of academic impact, for papers by Rosa Morros Breakdown of academic impact, for papers by Mojgan Mortazavi Breakdown of academic impact, for papers by Juana Carretero‐Gómez Breakdown of academic impact, for papers by Albert Marchetti Breakdown of academic impact, for papers by Mohamed Hassanein Breakdown of academic impact, for papers by Elisa Martín‐Merino Breakdown of academic impact, for papers by Ketut Suastika
Rankless by CCL
2026